Navigation Links
IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
Date:11/15/2011

MOUNTAIN VIEW, Calif., Nov. 15, 2011 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) announced it has entered into a license and distribution agreement with Alcon, the global leader in eye care, headquartered in Fort Worth, Texas.  The agreement covers the IRIDEX GreenTip™ Soft Tip Cannula family of products and license rights to the associated patented technology.  

IRIDEX GreenTip Soft Tip Cannula products are used in vitrectomy procedures and allow retina surgeons to effectively visualize and access the proximity of the retina. Benefits include: optimal contrast against the retina, maximized visualization and greater protection of the retina with its unique atraumatic silicone tip.

As part of the agreement, Alcon will pay $1.5 million in upfront royalties to IRIDEX, purchase IRIDEX branded products for distribution in the U.S. and pay an ongoing royalty to license and manufacture related Alcon branded products for distribution overseas.

"An important part of our growth strategy is to develop and identify unique consumable products that bring clinical value to retina surgeons and their patients, and we are very pleased to be working with Alcon in distributing a key product family in that category," commented Dr. Dominik Beck, President & CEO. "Working with Alcon, the market leader in ophthalmology devices, underscores the value of our enhanced visualization cannula products and may lead to additional opportunities for collaboration in the future."

About IRIDEX Corporation

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's strategic growth initiatives, relationship with Alcon and future collaboration opportunities.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 1, 2011 and our Quarterly Reports on Form 10-Q for the quarters ended April 2, 2011, July 2, 2011 and October 1, 2011, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
2. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
3. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
4. IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO
5. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
6. IRIDEX Expands ENT Laser Applications
7. IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter
8. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
9. IRIDEX Announces First Quarter 2011 Conference Call and Release Date
10. IRIDEX to Present at the Roth OC Growth Stock Conference in Dana Point, CA
11. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):